Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Hundreds of beachgoers pack in without social distancing in July. Photo: Matthew J. Lee/The Boston Globe via Getty Images

People in their 20s accounted for more than 20% of all COVID-19 cases between June and August, analysis from the Centers for Disease Control and Prevention shows, bringing the median age of coronavirus patients to 37, down from 46 in the spring.

Why it matters: Young people are less vulnerable to serious illness, but they contributed to community spread over the summer, the analysis says — meaning they likely infected older, higher-risk people, especially in the South.

Go deeper

Dec 31, 2020 - Health

WHO lists Pfizer COVID-19 vaccine for emergency use

A healthcare worker giving a patient a dose of Pfizer-BioNTech's coronavirus vaccine in Florida on Dec. 30. Photo: Marco Bello/Anadolu Agency via Getty Images

The World Health Organization on Thursday listed Pfizer-BioNTech's COVID-19 vaccine for emergency use.

Why it matters: The approval — the WHO's first for a coronavirus vaccine — may allow some countries to expedite their own regulatory approval processes so they can import and administer the vaccine quicker, the WHO said.

Dec 31, 2020 - Health

U.S. set to end 2020 with just over 3 million vaccine doses administered

A healthcare worker hands Patrick Range, Sr., 88, a vaccination card after giving him the Pfizer/BioNTech vaccine at Jackson Memorial Hospital in Miami on Dec. 30. Photo: Marco Bello/Anadolu Agency via Getty Images

Americans received just over 3 million initial doses of coronavirus vaccines from Moderna and Pfizer-BioNTech in the 19 days following first shipments, according to a Bloomberg tally of government websites and CDC data.

Why it matters: It's far below Operation Warp Speed's goal of administering 20 million doses by the end of the year, raising concerns about how long it may be until enough people are vaccinated in the U.S. for life to return to normal.

Updated 3 hours ago - Health

California surpasses 50,000 COVID-19 deaths

A man prepares a funeral arrangement in in Los Angeles, California, Feb. 12. Photo: Mario Tama/Getty Images

California's death toll from COVID-19 surpassed 50,000 on Wednesday, per Johns Hopkins data.

The big picture: It's the first state to record more than 50,000 deaths from the coronavirus.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!